stockrow
Friday 6 November 2026
Export A’s income statement to Excel — free account
Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024.
- Revenue
- +8.06%
- EPS
- +8.47%
- Free cash flow
- +69.5%
- Total debt
- +8.81%
Quarter to July 2026, against a year earlier
171.89
5.28
−2.98%
Follow A
Alert me
| Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 | Oct '20 | Oct '19 | Oct '18 | Oct '17 | Oct '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
31.96 | 29.35 | 24.50 | 32.94 | 39.46 | 45.17 | 22.35 | 64.79 | 31.94 | 30.90 |
Piotroski F-Score |
5 | 5 | 6 | 7 | 7 | 5 | 5 | 7 | 8 | 8 |
P/S ratio |
5.98 | 5.80 | 4.45 | 6.04 | 7.56 | 6.09 | 4.61 | 4.23 | 4.90 | 3.38 |
Altman Z-Score |
5.46 | 5.07 | 5.15 | 6.17 | 6.69 | 5.08 | 4.05 | 4.39 | 4.90 | 4.71 |
Altman Z″-Score (non-manufacturers) |
3.48 | 3.23 | 3.90 | 3.39 | 3.30 | 3.02 | 2.49 | 3.85 | 4.27 | 6.60 |
P/FCF ratio |
36.02 | 27.58 | 20.66 | 40.64 | 36.87 | 40.50 | 27.47 | 22.83 | 30.72 | 21.72 |
Beneish M-Score |
(2.46) | (2.64) | (2.72) | (2.34) | (2.49) | (2.48) | (2.24) | (2.79) | (2.47) | (2.64) |
P/Operating CF |
76.27 | 78.57 | 58.90 | 92.34 | 108.27 | 86.26 | 75.75 | 55.91 | 76.06 | 60.70 |
Dividend Safety Score |
86 | — | — | — | — | — | — | — | — | — |
P/B ratio |
6.17 | 6.41 | 5.20 | 7.80 | 8.86 | 6.67 | 5.01 | 4.55 | 4.53 | 3.35 |
Price to Tangible BV |
22.80 | 43.24 | 21.55 | 77.76 | 110.27 | 73.91 | 495.53 | 18.79 | 11.73 | 10.82 |
EV/Sales |
6.16 | 6.11 | 4.62 | 6.29 | 7.74 | 6.25 | 4.69 | 4.14 | 4.70 | 3.29 |
EV/EBITDA |
24.24 | 22.81 | 19.45 | 22.25 | 29.32 | 28.91 | 20.52 | 18.27 | 20.64 | 16.05 |
EV/Operating CF |
27.47 | 22.73 | 17.80 | 32.81 | 32.93 | 36.22 | 23.70 | 18.72 | 23.65 | 17.43 |
EV/FCF |
37.11 | 29.06 | 21.44 | 42.29 | 37.76 | 41.55 | 27.94 | 22.34 | 29.49 | 21.13 |
Quick Ratio |
1.40 | 1.40 | 1.80 | 1.32 | 1.61 | 1.69 | 1.11 | 2.58 | 2.69 | 3.09 |
Current Ratio |
1.96 | 2.09 | 2.61 | 2.03 | 2.22 | 2.33 | 1.53 | 3.29 | 3.30 | 3.85 |
Net Debt/EBITDA |
0.71 | 1.16 | 0.71 | 0.87 | 0.69 | 0.73 | 0.35 | (0.40) | (0.86) | (0.45) |
Debt/Assets |
23.96% | 28.24% | 25.41% | 25.95% | 25.49% | 23.72% | 18.95% | 21.06% | 21.37% | 24.43% |
Debt/Equity |
0.45 | 0.57 | 0.47 | 0.52 | 0.51 | 0.47 | 0.38 | 0.39 | 0.37 | 0.45 |
Asset Turnover |
0.57 | 0.58 | 0.64 | 0.64 | 0.62 | 0.56 | 0.57 | 0.58 | 0.55 | 0.55 |
Operating CF/Net income |
1.20 | 1.36 | 1.43 | 1.05 | 1.23 | 1.28 | 0.95 | 3.44 | 1.30 | 1.72 |
Capex/Depreciation |
(1.41) | (1.47) | (1.10) | (0.92) | (0.59) | (0.38) | (0.66) | (0.84) | (0.83) | (0.56) |
Interest Coverage |
13.21 | 15.50 | 14.21 | 19.26 | 16.63 | 10.85 | 12.72 | 12.05 | 10.22 | 8.54 |
| 20.62% | 21.95% | 22.24% | 23.45% | 23.58% | 14.95% | 22.99% | 6.72% | 15.06% | 10.98% | |
| 10.61% | 11.40% | 11.65% | 11.81% | 11.90% | 7.54% | 11.90% | 3.72% | 8.43% | 6.05% | |
ROIC |
11.55% | 11.75% | 12.07% | 14.48% | 12.87% | 9.25% | 11.40% | 13.70% | 12.74% | 9.96% |
Return on Tangible Assets |
30.52% | 33.55% | 32.18% | 41.56% | 39.86% | 25.74% | 54.67% | 9.03% | 18.67% | 13.88% |
Average Days of Receivables |
78.12 | 74.23 | 68.96 | 74.89 | 67.70 | 70.96 | 65.75 | 57.64 | 59.09 | 54.81 |
Research and Development Expense of Revenue |
6.55% | 7.36% | 7.04% | 6.82% | 6.98% | 9.27% | 7.82% | 7.88% | 7.63% | 7.83% |
Selling, General and Administrative Expense of Revenue |
24.60% | 24.09% | 23.91% | 23.90% | 25.62% | 28.02% | 28.28% | 28.27% | 27.97% | 29.82% |
Intangible Assets out of Total Assets |
0.39 | 0.42 | 0.41 | 0.45 | 0.46 | 0.46 | 0.50 | 0.41 | 0.35 | 0.38 |
Share Based Compensation of Revenue |
1.84% | 1.98% | 1.62% | 1.83% | 1.74% | 1.55% | 1.39% | 1.42% | 1.34% | 1.38% |
Graham Net Nets |
(0.03) | (0.05) | (0.02) | (0.03) | (0.03) | (0.04) | (0.06) | (0.01) | 0.03 | 0.01 |
Graham Number |
49.46 | 45.08 | 43.45 | 40.95 | 39.84 | 28.75 | 33.96 | 17.90 | 26.83 | 20.33 |
Earnings Yield |
3.13% | 3.41% | 4.08% | 3.04% | 2.53% | 2.21% | 4.48% | 1.54% | 3.13% | 3.24% |
Free Cash Flow Yield |
2.78% | 3.63% | 4.84% | 2.46% | 2.71% | 2.47% | 3.64% | 4.38% | 3.25% | 4.60% |
Revenue per Share |
24.46 | 22.45 | 23.24 | 22.90 | 20.79 | 17.28 | 16.44 | 15.31 | 13.89 | 12.89 |
Operating CF per Share |
5.49 | 6.04 | 6.03 | 4.39 | 4.88 | 2.98 | 3.25 | 3.39 | 2.76 | 2.43 |
Capex per Share |
(1.43) | (1.30) | (1.01) | (0.97) | (0.62) | (0.38) | (0.50) | (0.55) | (0.55) | (0.43) |
Free Cash Flow per Share |
4.06 | 4.73 | 5.01 | 3.41 | 4.27 | 2.60 | 2.75 | 2.84 | 2.21 | 2.01 |
Cash per Share |
6.30 | 4.58 | 5.41 | 3.52 | 5.18 | 4.66 | 4.40 | 7.00 | 8.32 | 7.02 |
Shareholders Equity per Share |
23.74 | 20.34 | 19.88 | 17.74 | 17.73 | 15.77 | 15.12 | 14.24 | 15.02 | 13.02 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
23.74 | 20.34 | 19.88 | 17.74 | 17.73 | 15.77 | 15.12 | 14.24 | 15.02 | 13.02 |
Free Cash Flow |
1,152.00 | 1,373.00 | 1,474.00 | 1,021.00 | 1,297.00 | 803.00 | 865.00 | 911.00 | 713.00 | 654.00 |
Working Capital |
2,247.00 | 2,064.00 | 2,583.00 | 1,917.00 | 2,091.00 | 1,948.00 | 1,109.00 | 2,677.00 | 2,906.00 | 2,690.00 |
Capital Expenditures |
(407.00) | (378.00) | (298.00) | (291.00) | (188.00) | (118.00) | (156.00) | (176.00) | (176.00) | (139.00) |
Net Current Asset Value |
(1,392.00) | (1,989.00) | (732.00) | (1,449.00) | (1,517.00) | (1,339.00) | (1,515.00) | (122.00) | 578.00 | 87.00 |
EV/EBIT |
28.96 | 26.75 | 23.36 | 26.60 | 36.30 | 39.44 | 25.71 | 22.51 | 26.06 | 22.47 |
Capex to Sales |
0.06 | 0.06 | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 |
Price to Operating Income |
28.10 | 25.40 | 22.51 | 25.57 | 35.45 | 38.44 | 25.28 | 23.01 | 27.14 | 23.10 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.14 | 0.21 | 0.29 | 0.34 | 0.36 | 0.28 | 0.26 | 0.28 | 0.39 |
Cash ROIC |
9.95% | 12.99% | 14.49% | 11.23% | 13.38% | 9.34% | 10.92% | 10.57% | 7.66% | 7.75% |
Accounts Receivable Turnover |
4.94 | 4.98 | 5.07 | 5.31 | 5.72 | 5.43 | 6.05 | 6.55 | 6.60 | 6.79 |
Accounts Payable Turnover |
5.96 | 6.21 | 6.75 | 6.09 | 7.28 | 7.07 | 6.80 | 6.93 | 7.38 | 7.48 |
Inventory Turnover |
3.31 | 2.97 | 3.26 | 3.35 | 3.76 | 3.58 | 3.58 | 3.68 | 3.74 | 3.73 |
Average Days of Payables |
62.95 | 66.25 | 45.30 | 67.72 | 55.90 | 51.64 | 54.80 | 55.55 | 53.70 | 46.79 |
Days of Inventory on Hand |
113.20 | 119.25 | 111.73 | 121.20 | 104.04 | 105.04 | 105.10 | 104.24 | 101.24 | 97.03 |
Average Receivables |
1,405.50 | 1,307.50 | 1,348.00 | 1,288.50 | 1,105.00 | 984.00 | 853.00 | 750.00 | 677.50 | 618.50 |
Average Payables |
555.00 | 479.00 | 499.00 | 513.00 | 400.00 | 354.00 | 347.00 | 322.50 | 281.00 | 268.00 |
Average Inventory |
998.50 | 1,001.50 | 1,034.50 | 934.00 | 775.00 | 699.50 | 658.50 | 606.50 | 554.00 | 537.00 |
Average Assets |
12,286.50 | 11,304.50 | 10,647.50 | 10,618.50 | 10,166.00 | 9,539.50 | 8,996.50 | 8,483.50 | 8,110.00 | 7,636.50 |
Average Common Equity |
6,319.50 | 5,871.50 | 5,575.00 | 5,347.00 | 5,131.00 | 4,810.50 | 4,659.50 | 4,703.00 | 4,540.50 | 4,208.00 |
Columns are period end dates